Publications by authors named "G Miltgen"
Introduction: The increasing resistance of Helicobacter pylori to clarithromycin leads to an ongoing adaptation of empirical first-line treatment for H. pylori infections.
Patients And Methods: Prospective study (2022-2023) of 364 patients with no previous treatment for H.
Carbapenemase-producing Enterobacterales are pathogens classified as a critical priority by the World Health Organization and a burden on human health worldwide. IMI, NmcA, and FRI are under-detected class A carbapenemases that have been reported in the human, animal and environmental compartments, particularly these last 5 years. Bacteria producing these carbapenemases have been mostly identified in digestive carriage screenings, but they are also involved in severe infections, such as bacteremia.
View Article and Find Full Text PDFAcinetobacter baumannii (Ab) has emerged in the last decades as a cause of community-acquired pneumonia (CAP) in tropical and subtropical regions. We previously conducted the first investigation on this topic in France with a case series of severe CAP-Ab in Reunion Island over an eight-year period. In the present work, we aim to highlight the specific aspects of CAP-Ab by comparing our case series with an historical cohort (PAC_RUN), obtained by retrospective chart review (2016-2021) of severe community-acquired pneumonia cases on Reunion Island, in which CAP-Ab was ruled out.
View Article and Find Full Text PDFArticle Synopsis
- Carbapenem-resistant Acinetobacter baumannii (CRAB) is a major global health concern, particularly in bloodstream infections, making early detection vital for effective treatment.
- The RESIST ACINETO immunochromatographic assay accurately detects key carbapenemases (OXA-23, OXA-40/58, NDM) in clinical isolates, demonstrating perfect sensitivity and specificity in both bacterial and blood cultures.
- Utilizing RESIST ACINETO can enhance rapid identification of CRAB in high-incidence regions like the Balkans and Southeast Asia, facilitating optimized treatment strategies, especially with alternatives like cefiderocol.